The themes Elevance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Die Umsatzanteile sind Schätzungen für year ended December 31, 2025 und keine Zahlen aus einem eingereichten Bericht.
Employer and individual health plans
Medical insurance plans sold to employers and individuals, with members using contracted doctors and hospitals or paying different amounts for out-of-network care.
Medicare plans
Health coverage for people eligible for Medicare, including Medicare Advantage plans that provide a managed-care alternative to traditional Medicare.
Medicaid plans
State-sponsored health coverage for eligible low-income people, older adults, and people with disabilities.
Employer health-plan administration
Claims processing, access to a network of doctors and hospitals, and care-management services for employers that pay their workers’ medical claims themselves.
CarelonRx pharmacy services
Prescription claims processing, drug-coverage management, pharmacy networks, home delivery, specialty pharmacies, and infusion services.
Carelon Health and Carelon Insights services
Care and support for people with complex health needs, including behavioral health and in-home or virtual care, alongside services that help health plans and providers manage care and process claims.
Elevance Health collects premiums for health plans covering individuals, employees, and people enrolled in Medicare and Medicaid. It also administers health plans funded by employers and sells pharmacy and care services to its own health plans and outside customers. Its affiliated health plans served 44.9 million medical members (June 30, 2026, high).
Gebaut aus den eigenen Einreichungen von Elevance Health, Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
429,55 $-0,1 %Schluss 13. Nov.
Zahlen bis 30. September 2026, aus dem 10-Q vom 21. Oktober 2026
Elevance Health sells health insurance to individuals, employers, and government programs, plus pharmacy and care services to health plans and patients.
Grade C
Das Band unter dem Kurs zeigt die Note an jedem Tag – gebildet nur aus den Unterlagen, die bis dahin veröffentlicht waren.
Zeigt 2 von 41 Quartalen der Notenhistorie von Elevance Health, Inc.. Die übrigen 39 reichen zurück bis November 2016.